Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Transplant Diagnostics by Year
Transplant Diagnostics (One Lambda HLA Transplant Diagnostics) ($M)
Thermo Fisher Scientific Transplant Diagnostics: $492M in FY2025, up 8.4% from a year earlier.
Where the FY2025 figure comes from
“|| Transplant diagnostics | 492 | 454 | 393”
Source: SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Reported in SEC 10-K / 10-Q Note 6 (Revenue by Business).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Transplant Diagnostics (One Lambda HLA Transplant Diagnostics) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 492 | +8.4% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 454 | +15.5% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 393 | – | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Transplant Diagnostics ($M), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-biz-transplant-diagnostics
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.